Home
Dr. Luke Dreisbach
Publications
Luke Dreisbach
Hematology | Oncology
760-568-3613
34490 Bob Hope Dr
Rancho Mirage, CA 92270
Save
Share
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Filter
(0)
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Journal:
Nature medicine
Published:
May 07, 2020
VIEW PUBLICATION
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Journal:
Cancer
Published:
April 02, 2013
VIEW PUBLICATION
Showing 1-2 of 2
Last Updated: 09/26/2026